A Study Of Moderately Hypo-Fractionated External-beam Radiotherapy With Concurrent Chemotherapy and High Dose Rate Brachytherapy In Cervical Cancer

Cancer of the uterine cervix is one of the most common gynecologic cancer diagnosis and cause of death among gynecologic cancers worldwide .The two major histologic types of cervical cancer are squamous cell carcinoma, adenocarcinoma and the preinvasive disease that corresponds with these histologies share many of the same risk factors . Cancer cervix can be treated definitively with concurrent chemoradiation (external beam radiotherapy and chemotherapy) followed by high dose rate brachytherapy. Treatment duration can be shortened by increasing the dose per fraction of treatment, which can im

Trial Details

NCT ID
NCT07343531
Phase
NA
Sponsor
Ain Shams University
Status
RECRUITING
Cancer Type
Adenocarcinoma Cervical Cancer
Interventions
  • moderate hypofractionation external beam radiotherapy
Locations (sample)
  • Cairo, Cairo Governorate, Egypt|30.06263,31.24967

Key Eligibility Criteria

  • Age 18 years or older.
  • International Federation of Gynecology and Obstetrics (FIGO) IB1 cervical cancers if not surgical candidates, but amenable to definitive chemoradio…
  • FIGO Stage IB2, IB3, IIA or IIB cervical cancers
  • FIGO stage IIIA, IIIB.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Adenocarcinoma Cervical Cancer Trials on Trialify →